Bax inhibitor peptide, negative control
Negative control peptide for the Bax inhibitor peptide V5 (Cat. No. 1785), which inhibit Bax translocation to mitochondria and Bax-mediated apoptosis in vitro.
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 1 mg/ml in water|
Preparing Stock Solutions
The following data is based on the product molecular weight 600.82. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.66 mL||8.32 mL||16.64 mL|
|5 mM||0.33 mL||1.66 mL||3.33 mL|
|10 mM||0.17 mL||0.83 mL||1.66 mL|
|50 mM||0.03 mL||0.17 mL||0.33 mL|
References are publications that support the products' biological activity.
Yoshida et al (2004) Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem.Biophys.Res.Commun. 321 961 PMID: 15358121
Sawatzky et al (2006) The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am.J.Pathol. 168 33 PMID: 16400007
If you know of a relevant reference for Bax inhibitor peptide, negative control, please let us know.
View Related Products by Product Action
Keywords: Bax inhibitor peptide, negative control, supplier, Negative, control, peptide, 5, 1786, Bax, Bcl-XL, Mcl-1, Bcl-2, Family, Bcl-2, Family, Bcl-2, Family, Tocris Bioscience
1 Citation for Bax inhibitor peptide, negative control
Citations are publications that use Tocris products. Selected citations for Bax inhibitor peptide, negative control include:
Lee et al (2010) Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J Cell Sci 123 1634 PMID: 20406888
Do you know of a great paper that uses Bax inhibitor peptide, negative control from Tocris? If so please let us know.
Bax inhibitor peptide, negative control Reviews
Average Rating:(Based on 0 Reviews)
Literature in this Area
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.
Programmed Cell Death Poster
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.